Skip to main content
TipRanks
Go Ultimate75% OFF

Colan Totte.Co.,Ltd. (7792) AI Stock Analysis

0 Followers
JP:7792

Colan Totte.Co.,Ltd.

(TSE/TYO:7792)

Select Model
Rating:75Outperform
Price Target:JPY 1,593.00â–²(12.74% Upside)
Action:reiterated
Date:11/12/26

The overall score of 75 is primarily driven by exceptional financial health, highlighted by strong revenue growth and zero structural debt, alongside an attractive valuation with a low P/E and solid dividend yield. However, short-term bearish technical trends, with the stock trading below key near-term moving averages, slightly weigh down the final rating.

Positive Factors
Strong Revenue GrowthRevenue has more than doubled across the reported period, demonstrating substantial commercial expansion and sustained demand for the company’s offerings. Continued top-line growth broadens the earnings base, supports operating leverage, and provides resources to reinforce products, channels, and market position over the next several quarters.
Negative Factors
Uneven Cash ConversionCash generation has not consistently matched reported earnings, and free cash flow has moved sharply between periods. This reduces the predictability of internally generated funds, complicates capital planning, and means strong accounting profitability may not translate evenly into cash available for investment or distributions.

Colan Totte.Co.,Ltd. (7792) vs. iShares MSCI Japan ETF (EWJ)

-10%-5%0%5%10%15%20%25%30%JP:7792+0.78%EWJ+14.66%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 12.68B
Dividend Yield
3.54%
Average Volume (3M)
13.01K
Price to Earnings (P/E)
8.5
Beta (1Y)
0.51
Revenue Growth
30.12%
EPS Growth
13.38%
Country
Japan
Employees
104
Sector
General
Sector Strength
55
Industry
Medical - Devices

Colan Totte.Co.,Ltd. Business Overview & Revenue Model

Company Description

Colan Totte Co., Ltd., established in Osaka, Japan, in 1997, operates as an international firm specializing in the development and global distribution of therapeutic devices under its proprietary Colantotte brand. The company's diverse product portfo...

Colan Totte.Co.,Ltd. Financial Statement Overview

Summary

Outstanding financial profile with consistent 30% top-line growth, expanding profit margins, and a pristine, debt-free balance sheet generating strong returns on equity.

Income Statement

88Very Positive

Balance Sheet

95Very Positive

Cash Flow

78Positive
Financial statement breakdown
BreakdownTTMSep 2026Sep 2025Sep 2024Sep 2023Sep 2022
Income Statement
Total Revenue8.02B9.00B6.92B5.94B5.41B4.66B
Gross Profit5.46B6.30B4.66B3.97B3.45B3.04B
EBITDA2.06B2.35B1.90B1.57B1.10B1.02B
Net Income1.35B1.51B1.33B1.02B645.02M610.45M
Balance Sheet
Total Assets7.18B7.92B6.74B5.43B4.91B4.13B
Cash, Cash Equivalents and Short-Term Investments2.11B2.50B2.18B1.76B1.79B1.34B
Total Debt8.05M9.67M12.90M8.69M1.27M270.48M
Total Liabilities1.62B1.62B1.57B1.32B1.64B1.38B
Stockholders Equity5.55B6.30B5.17B4.11B3.27B2.75B
Cash Flow
Free Cash Flow1.06B730.15M728.70M357.26M867.34M75.48M
Operating Cash Flow1.48B1.19B998.35M883.77M955.70M148.09M
Investing Cash Flow-471.40M-487.70M-303.40M-736.91M-83.80M-80.38M
Financing Cash Flow-654.18M-383.00M-272.18M-180.15M-410.10M-274.23M

Colan Totte.Co.,Ltd. Technical Analysis

Technical Analysis SentimentNeutral
Last Price1413.00

Price Trends

50DMA1447.69Negative
100DMA1427.14Positive
200DMA1412.04Positive

Market Momentum

MACD-4.93Negative
RSI47.38Neutral
STOCH72.64Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7792, the sentiment is Neutral. The current price of 1413.00 is below the 20-day moving average (MA) of 1442.75, below the 50-day MA of 1447.69, and above the 200-day MA of 1412.04, indicating a neutral trend. The MACD of -4.93 indicates Negative momentum. The RSI at 47.38 is Neutral, neither overbought nor oversold. The STOCH value of 72.64 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:7792.

Colan Totte.Co.,Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

JP:7792 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:7792JP:779275OutperformJPY 12.89B8.51―3.54%30.12%13.38%
JP:5187JP:518774OutperformJPY 10.05B25.90―4.34%3.38%-52.61%
JP:6849JP:684963NeutralJPY 254.11B20.98―2.06%-0.18%-33.38%
JP:6523JP:652361NeutralJPY 165.53B11.488.71%3.23%2.74%145.33%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
JP:4549JP:454950NeutralJPY 73.85B39.86―2.59%3.92%-52.01%
JP:7600JP:760045NeutralJPY 8.06B-5.18―5.56%-8.68%-75.03%

* General Sector Average

Performance Comparison

0%50%100%JP:7792JP:6523JP:4549JP:5187JP:6849JP:7600Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:7792 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:7792Colan Totte.Co.,Ltd.1413.008.090.58%
JP:6523PHC Holdings Corp.1300.00374.1940.42%
JP:4549Eiken Chemical Co., Ltd.2240.0037.761.71%
JP:5187Create Medic Co., Ltd.1105.00150.2015.73%
JP:6849Nihon Kohden Corporation1550.0020.561.34%
JP:7600Japan Medical Dynamic Marketing, Inc.306.00-165.73-35.13%

Colan Totte.Co.,Ltd. Corporate Events

Colan Totte Reports Higher Sales, Profits and Dividend

Nov 6, 2026

Colan Totte Co., Ltd. is listed on the Tokyo Stock Exchange, but the release does not provide details about its industry or primary products. For the fiscal year ended September 30, 2026, the company reported net sales of ¥9,001 million, up 30.1% yea...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 12, 2026